Navigation Links
MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM)
Date:11/26/2008

LOS GATOS, Calif., Nov. 26 /PRNewswire/ -- TriCipher, the experts in strong authentication, today announced that its MySignatureBook digital signing solution has been certified as compliant with the SAFE-BioPharma(TM) digital identity and signature standard.

MySignatureBook 1.1 is an online digital signature workflow solution that manages the collection and application of digital signatures to PDF documents using Adobe Reader. The ability to leverage SAFE-BioPharma credentials for signing allows MySignatureBook to manage the signature process for many regulated and highly sensitive documents that are incredibly common to the life sciences industry.

"Digital signatures that meet the SAFE-BioPharma digital standard are accepted by the FDA and meet legal signature standards across the EU and the European Economic Area," said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. "Compliance with the SAFE-BioPharma standard means our members and TriCipher customers can have confidence in MySignatureBook when it is used with SAFE-BioPharma credentials."

MySignatureBook 1.1, announced today, is the second major enhancement of the online digital signing solution and is already deployed across several companies in the pharmaceutical and healthcare industries. New features include a truly zero-footprint client option and the ability to sign and manage groups of documents for companies with high-volume signature requirements.

"We have worked closely with our major customers in the life sciences industry to develop the features in MySignatureBook 1.1," said John De Santis, president and CEO of TriCipher. "Certification with the SAFE-BioPharma standard underlines our commitment to industry standards and supporting the pharmaceutical and healthcare communities."

TriCipher and SAFE-BioPharam will host a joint webcast on December 16th on digital signatures in the pharma
'/>"/>

SOURCE TriCipher, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners
2. QualityMetric Announces QM Certified Scoring Program
3. Saving Certified Continuing Medical Education (CME)
4. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
5. Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY
6. Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager
7. Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory
8. BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork
9. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
10. Free CME-certified Webcast: Making Your Case: Up-to-date Answers for Developing Trends in PCI
11. Halal-Certified Products Introduced Into SAFC Supply Solutions Flavors & Fragrances Food-Grade Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of ... results for the fourth quarter and full year ended ... Highlights(Compared to the fourth quarter 2013) , Quarterly ... from $22.9 million in the prior year period. Excluding ... vaccine of $0.1 million in the fourth quarter of ...
(Date:4/17/2015)... 17, 2015  Centrillion Technologies, a genomic ... from the National Human Genome Research Institute, ... (NIH). The grant will help fund the ... of breakthrough genomic technologies, including phased sequencing ... Centrillion has been developing this transformative and ...
(Date:4/17/2015)... -- US-Australian drug discovery company, Novogen, today announced that ... the Feinstein Institute for Medical Research (,Feinstein Institute,) ... collaborate with the objective of developing effective treatments ... together the drug discovery expertise of Novogen and ... Institute in neurosciences and oncology. At ...
(Date:4/16/2015)... OSAKA, Japan , April 16, 2015 ... of Kyoto University and Takeda Pharmaceutical Company Limited ... to develop clinical applications of induced pluripotent stem ... mellitus, neurological disorders and cancer immunotherapy. The "Takeda-CiRA ... designed to expedite multiple research projects for drug ...
Breaking Biology Technology:Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3
... are not teaching skills needed for the Information Age. Their ... that we are way beyond the Industrial Age. , ... Rs. I am not talking about reading, writing and `rithmetic; ... these add up to regimentation, which is what was needed ...
... CleanTech Partners will receive $1.5 million from the ... attempt to produce cellulosic ethanol at paper mills by extracting ... paper making. , ,Masood Akhtar, president of CleanTech Partners and ... for the grant. Other participants included the United ...
... Wis. - The origins of Madison's technology industry can ... pretty isolated when he opened DNASTAR, Inc . that year. ... Promega - and a few more, the producer of DNA ... an era where it was considered bad form - even a ...
Cached Biology Technology:Rote education fails the Information Age 2Rote education fails the Information Age 3Rote education fails the Information Age 4DNASTAR catches second wave of sequencing 2DNASTAR catches second wave of sequencing 3DNASTAR catches second wave of sequencing 4
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:4/1/2015)... Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces the ... wallets is underway to early access pre-order customers. ... usage at retail outlets including Walmart, Target, AT&T, Dunkin, ... Wocket was accepted at all outlets and very easy ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... in which babies are born can have a dramatic ... That is the conclusion of a new study published ... Neuroscience . The experiment provides the first evidence for ... conducted by Professor of Biological Sciences Douglas McMahon, graduate ...
... for the first time that exactly how we see our environment ... We are all familiar with the idea that our thoughts ... assume that how we perceive the visual world is usually very ... the area at the back of the brain responsible for processing ...
... reversed by activating stem cells that can repair injury in ... from the Universities of Cambridge and Edinburgh have identified a ... sheaths that protect nerve fibres in the brain. ... can be exploited to make the brain,s own stem cells ...
Cached Biology News:Babies' biological clocks dramatically affected by birth light cycle 2Babies' biological clocks dramatically affected by birth light cycle 3Babies' biological clocks dramatically affected by birth light cycle 4Babies' biological clocks dramatically affected by birth light cycle 5Seeing the world differently 2Study reveals new possibility of reversing damage caused by MS 2
Each 72-well MiniTray is low profile, with lid. Conical well shape, 10 l....
... Clone/PAD: ZMD.283. Immunogen: Fusion protein ... Specific for ASIP/PAR-3 (atypical PKC isotype-specific ... antigen is not related to the ... Human Dog Xenopus (positive controls: Caco-2 ...
For use with SSP products or any application requiring agarose gel separation • Multiple formats available to meet various throughput needs • Includes replacement parts for each un...
Request Info...
Biology Products: